HHG
HYGEIA Hospital
METROPOLITAN HOSPITAL
ΜΗΤΕΡΑ
METROPOLITAN GENERAL
ΛΗΤΩ Μαιευτικό, Γυναικολογικό & Χειρουργικό Κέντρο
Creta InterClinic – Ιδιωτική Κλινική | Διαγνωστικό Κέντρο
AlfaLab | Kέντρο Μοριακής Βιολογίας & Κυτταρογενετικής
Y-Logimed Α.Ε.
Business Care
Healthspot
Digital Clinic
HEAL
IVF

The Transcatheter Heart Valve Department has been operating since 2010. The Department staff have performed more than 2.000 transcatheter aortic valve replacements (the most in Greece), with all types of valves available today (SAPIEN Ultra, Edwards Lifesciences; Evolut PRO, Medtronic; Portico, Abbott; ACURATE neo2, Boston Scientific; JenaValve) and using all possible implantation methods (transfemoral, transaortic, transthoracic or transapical and subclavian route).

The HYGEIA Hospital Transcatheter Heart Valve Department is or has been an official global training center for the SAPIEN 3 valves by Edwards Lifesciences and the Evolut R valves by Medtronic, while its medical staff are worldwide trainers for the placement of valves manufactured by Edwards and Medtronic.

The Transcatheter Heart Valve Department successfully introduced the transcatheter mitral valve regurgitation repair using the MitraClip system (Abbott Vascular) in Greece in 2011, and more recently (2019) the PASCAL system (Edwards Lifesciences), and more than 350 clips have been implanted to this day. The Department medical staff are trainers for the MitraClip and PASCAL procedures.

In addition, the Department performed the first transcatheter tricuspid valve repairs in Greece in 2015, while the program is continuing with the use of various devices (TriClip, PASCAL).

All transcatheter procedures are performed in the state-of-the-art HYGEIA Hybrid Operating Room.

Director of Transcatheter Heart Valves Department is Konstatinos Spargias

Attending Physicians
Stratos Pattakos, Director

Nikolaos Mpoumpoulis, Αssoc. Director
Grigorios Pattakos, Αssoc. Director
Michael Chrissoheris, Αssoc. Director

Panagiota Kourkoveli, Attending Physician

Dionisios Aravantinos, Attending Physician

Kyriakos Katsianos, Attending Phygsician

  • Transcatheter aortic valve replacement/implantation (SAPIEN Ultra, Edwards Lifesciences; Evolut PRO, Medtronic; ACURATE neo2, Boston Scientific; Navitor, Abbott; JenaValve)

  • Transcatheter mitral valve regurgitation repair (MitraClip, PASCAL)

  • Transcatheter mitral valve replacement (SAPIEN Ultra, Edwards Lifesciences and various devices as part of research)

  • Transcatheter tricuspid valve regurgitation repair (TriClip, PASCAL)

  • Transcatheter tricuspid valve replacement (SAPIEN Ultra, Edwards Lifesciences and various devices as part of research)

  • Transcatheter paravalvular leak closure

  • Transcatheter PFO and ASD closure

  • Cardiac valvuloplasty

  • Coronary angiography

  • Percutaneous coronary artery revascularization (angioplasty-stent)

  • Cardiac catheterizations

  •  Cardiac biopsy

  •  Pericardiocentesis

  •  Alcohol septal ablation

  •  Pulmonary hypertension reactivity testing

 

HYGEIA Transcatheter Heart Valve Department is or has been official worldwide training center for Edwards’ SAPIEN 3 valves, Medtronic’s Evolut R valves, and its medical staff are Edwards, Medtronic, and Mitraclip/PASCAL Proctors.

The Department is continuously organizing the first Specialized Conference on Transcutaneous Cardiac Valve Diseases (www.thvgreece.com) in Greece since 2012 with the participation of Greek and foreign scientists and distinguished MDs for the purpose of continuously informing and educating about the latest developments in this field.

The Department launched a new monthly educational activity entitled “TAVI Monthly Rounds” since February 2021 (https://www.livemedia.gr/tavirounds21)

   10th Transcatheter Heart Valves Greece 2021 (https://webtv.thvgreece.com/9thv)

    8th Conference on Transcatheter Cardiac Valve 2019

    7th Conference on Transcatheter Cardiac Valve 2018   

    6th Conference on Transcatheter Cardiac Valve 2017

    5th Conference on Transcatheter Cardiac Valve 2016

    4th Conference on Transcatheter Cardiac Valve 2015

    3rd Conference on Transcatheter Cardiac Valve 2014

    2nd Conference on Transcatheter Cardiac Valve 2013

    1st Conference on Percutaneous Treatment of Cardiac Valves 2012

The HYGEIA Hospital Transcatheter Heart Valve Department is one of the leading research centers globally for in use and new transcatheter devices for the treatment of cardiac valve repairs. Many Greek patients could benefit from the new technologies being clinically tested within the department. Contact the Transcatheter Heart Valve Department to find out all about the current protocols. The treatments may have already been approved or may be investigational. These studies are usually sponsored by manufacturers and are offered free of charge.

Some research protocols at the Transcatheter Heart Valve Department:

  • MiCLASP. PASCAL in mitral valve repair

  • TriCLASP. PASCAL in tricuspid valve repair

  • CardioValve. Transcatheter Mitral valve replacement with CardioValve

  • TriCares. Transcatheter Tricuspid valve replacement

  • RESHAPE HF2 (επιδιόρθωση ανεπάρκειας μιτροειδούς, MitraClip, Abbott)

  • RHEIA Study (TAVI vs SAVR in women)

  • Popular Study (antithrombotic treatment after TAVI)

 

+30 210 686 7310
+30 210 686 7311